Sponsored Link:

Page Analysis

Sponsored Link:

vincicapital.ch


http://www.vincicapital.ch/
155 ratings.258 user reviews.

Web page information

  1. Keywords hit in search results
    about access acquire acquires additional agency agreed anergis assists based basel berne billion biosurgery biotechnology brazil burckhardt business called capital christian chronic class commercialization communications companies company connected consortium creative cytos davinci dedicated develop development discovery diseases– economic electronic equity financing fraga funding geneva genevest greater growing growth immunodrugs™ independent info@davinci information insightful invest investor investors kuros leading leads linkedin management manufacturer medicines mergers million millions mission network novel opportunities owned peter platform polytechventures preventing private product provided radar raised raises sciences secure since start strategies subsidiary swiss systems technology their thousands under unteraegeri vinci vincicapital vital waldvogel wholly zuger
  2. Search Engine Recommended Keywords
    Creative Health Capital, Creative Health Capital LLC, Pinehurst Capital, Nexus Health Capital Dallas, CH Capital Partners, Channel Management, CNH Used Equipment, Creative Health Care Solutions Inc,
Home page - Private equity Vinci Capital
Vinci Capital is an independent Swiss private equity firm. Vinci’s mission is the financing and development of new Swiss-based technology companies: information ...
http://www.vincicapital.ch/
About Us - Private equity Vinci Capital
Vinci Capital is an independent Swiss private equity firm. Vinci’s mission is the financing and development of new Swiss-based technology companies: information ...
http://www.vincicapital.ch/en-us/private_equity/about.html
Cytos Biotechnology - Preventing Chronic Diseases– a Vital ...
Cytos Biotechnology is dedicated to the discovery, development and commercialization of a novel class of medicines – called Immunodrugs™. Immunodrugs™ are ...
http://www.cytos.ch/
KUROS BIOSURGERY AG RAISES CHF 5.6M (€ 3.6M) IN ADDITIONAL FUNDING
www.genevest.ch . Vinci Capital is an independent Swiss private equity firm with CHF 192 millions under management. Vinci’s mission is the financing and ...
http://www.kuros.ch/cms/upload/kuros_news/Oct_2005.pdf
Investor List | CTI Invest | Swiss Leading Financing Platform
EVA - the Basel life sciences start-up agency Peter Burckhardt www.eva-basel.ch ... Vinci Capital Christian Waldvogel www.vincicapital.ch
http://www.cti-invest.ch/Members/Member-List.aspx
Greater Geneva Berne area (GGBa) - economic development agency ...
www.polytechventures.ch. Vinci Capital is a leading Swiss private equity firm with more than SFr 200 million under management. Since 1998 the company has provided equity to ...
http://www.ggba-switzerland.ch/en/getting-started/capital-markets-and-financing/
Vinci Capital Acquires Swiss Radar Manufacturer - Mergers ...
A private equity consortium led by Vinci Capital agreed to acquire Creative Electronic Systems SA, the wholly-owned Swiss subsidiary of MRV Communications Inc.
http://www.themiddlemarket.com/news/tt_vinci_creative_electronic-230258-1.html
Da Vinci Capital Management | LinkedIn
Join LinkedIn and see how you are connected to Da Vinci Capital Management. It's free.Get access to insightful information about your network at thousands of companies!
http://www.linkedin.com/company/da-vinci-capital-management
Da Vinci Invest Ltd.
Da Vinci Invest AG, Da Vinci Invest AG, Zuger Str. 46, CH-6314 Unteraegeri, info@davinci-invest.ch
http://www.davinci-invest.ch/
Davinci Capital :: Private Equity Opportunities
DaVinci Capital assists seed, start-up and growing companies develop strategies for growth and to secure financing to fund their business ...
http://www.davincicapital.net/

News Results

Fraga Leads Brazil Private Equity Beyond India as Selic Falls
Brazilian buyout funds led by former central banker Arminio Fraga’s Gavea Investimentos Ltda., BTG Pactual (BBTG11) and Vinci Capital Gestora de Recursos raised $7.1 billion last year, up from $1.1 billion in the previous year, according to an ...
Businessweek
Anergis Reaches Important Milestones with Second Product Candidate AllerR
Anergis’ lead-product is currently in Phase II clinical development. Anergis raised CHF 18 million in March 2011 from lead investors Vinci Capital, Sunstone Capital and BioMedInvest and other investors including Esperante Ventures and Defi Gestion.
Phramalive.com
No Coupons found for this website.

500 characters left

Your Review: (5 out of 5)
refresh captcha


Server Information
IP Address: 188.165.181.32
Server:Apache/2.2.22 (Debian)
Powered By:PHP/5.4.27-1~dotdeb.1
Site Disclaimer:

All trademarks are the property of their respective owners. The facts, figures, reviews, records, stats, and other data presented on this page is for suggestion and information purposes only. PageGlimpse.com is not responsible for any incorrect or incomplete information. PageGlimpse.com does not take responsibility for any user-reviews of websites inside its resource and reserves the right to keep or remove those. It is highly recommended that you review all the data for accuracy.